Blog

In May of 2018, the Trump Administration committed to lowering the costs of prescription drugs and out-of-pocket spending for patients. One of the ways in which the Administration suggested meeting this goal was by changing the information available to consumers in television ads that market medications, which lead to a new rule that would require pharmaceutical companies to disclose the “list price” of drugs.

On December 5th, 2018 we presented new research findings on a study of more than 600 women with breast cancer at the San Antonio Breast Cancer Symposium in San Antonio, TX. Below is a post about the significance of these findings for women diagnosed with breast cancer and for breast cancer care providers.

Our Research and Training Institute (RTI) took front stage in sunny San Diego this week at the American Society of Hematology (ASH) Annual Meeting. Three abstracts from the RTI were accepted to the conference, each representing a separate blood cancer specialty registry from the Cancer Experience Registry^®.

The affiliate is the first CSC affiliate to be located in the state of New Hampshire. 

Each month, the Cancer Policy Insitute profiles advocates who have been engaged in advocacy in their home state, their community, with elected officials, and more. Read on to learn more about our featured advocate for the month of December and her recent dive into advocacy. If you are interested in learning more about policy, advocacy, and ways to get involved, sign up to be a part of the Grassroots Network!

CSC wins seven awards for its free online health resources. 

Our Research and Training Institute (RTI) has a new Executive Director, Kevin Stein, PhD. Read on below for a Q&A with Kevin (KS) and Operations Manager Levi James (LJ) to get to know the newest member of the RTI Team and his background in cancer research. 

For a special “Flashback Friday”, today we want to remind you of a useful resource that was launched at the beginning of the year in collaboration with our friends at Janssen Pharmaceuticals, along with two other leading patient advocacy organizations: the American Cancer Society and CancerCare.

Recently the Centers for Medicare and Medicaid Services (CMS) released new guidance for the Affordable Care Act’s section 1332 waivers, expanding the power of 1332s and allowing states to use the waivers to adjust traditional compliance with ACA requirements.

On Thursday, October 25, we officially welcomed Gilda’s Club Memphis into the Cancer Support Community’s international network of hope and support for all people affected by cancer.